Skip to main content
Top
Published in: International Journal of Clinical Oncology 1/2015

01-02-2015 | Original Article

Perception and needs of reproductive specialists with regard to fertility preservation of young breast cancer patients

Authors: Chikako Shimizu, Tomoyasu Kato, Nobuko Tamura, Hiroko Bando, Yoshimasa Asada, Yuri Mizota, Seiichiro Yamamoto, Yasuhiro Fujiwara

Published in: International Journal of Clinical Oncology | Issue 1/2015

Login to get access

Abstract

Background

Treatment-related infertility is one of the important quality-of-life issues in young breast cancer (YBC) patients. Although existing guidelines recommend supporting fertility preservation (FP) of YBC, the perceptions of reproductive specialists (RS) has not been evaluated. We investigated the perceptions and needs of RS with regard to FP of YBC patients.

Methods

A cross-sectional survey was sent to 423 certified RS registered to the Japan Society for Reproductive Medicine to self-evaluate their perceptions and needs regarding FP in YBC patients.

Results

Two hundred RS (47 %) responded to the survey. 99 % responded that RS should be engaged in FP of YBC patients. 88 % responded that they would like to treat YBC patients, while 46 % responded that cancer treatment is more important than childbirth, even when the patient is recurrence-free 5 years after primary treatment. Respondents affiliated to private clinics were more likely to accept both fertilized and unfertilized egg preservation than those affiliated with academic or general hospitals. 70 % responded that they were anxious about treating breast cancer patients: concerns regarding a greater or unknown risk of recurrence (66 %), insufficient knowledge about breast cancer (47 %), and lack of a patient’s spouse/partner (24 %) were identified as major barriers in supporting FP for YBC patients.

Conclusions

RS recognize the need for FP in YBC patients and are willing to participate in their care. Affiliation of RS was related to a positive attitude to egg preservation. Various concerns regarding FP among RS indicate the need for evidence that supports the safety of FP, inter-disciplinary communication, and practice guidelines.
Appendix
Available only for authorised users
Literature
1.
go back to reference Thewes B, Meiser B, Taylor A et al (2005) Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 23:5155–5165PubMedCrossRef Thewes B, Meiser B, Taylor A et al (2005) Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 23:5155–5165PubMedCrossRef
2.
go back to reference Peate M, Meiser B, Hickey M et al (2009) The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review. Breast Cancer Res Treat 116:215–223PubMedCrossRef Peate M, Meiser B, Hickey M et al (2009) The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review. Breast Cancer Res Treat 116:215–223PubMedCrossRef
3.
go back to reference Lee SJ, Schover LR, Partridge AH et al (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917–2931PubMedCrossRef Lee SJ, Schover LR, Partridge AH et al (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917–2931PubMedCrossRef
4.
go back to reference ISFP Practice Committee, Kim SS, Donnez J et al (2012) Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet 29:465–468PubMedCentralPubMedCrossRef ISFP Practice Committee, Kim SS, Donnez J et al (2012) Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet 29:465–468PubMedCentralPubMedCrossRef
5.
go back to reference Von Wolff MV, Montag M, Dittrich R et al (2011) Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet 284:427–435CrossRef Von Wolff MV, Montag M, Dittrich R et al (2011) Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet 284:427–435CrossRef
6.
go back to reference Klemp JR, Kim SS, on behalf of ISFP Practice Committee (2012) Fertility preservation in young women with breast cancer. J Assist Reprod Genet 29:469–472PubMedCentralPubMedCrossRef Klemp JR, Kim SS, on behalf of ISFP Practice Committee (2012) Fertility preservation in young women with breast cancer. J Assist Reprod Genet 29:469–472PubMedCentralPubMedCrossRef
7.
go back to reference Shimizu C, Bando H, Kato T, Mizota Y, Yamamoto S, Fujiwara Y (2013) Physician’s knowledge, attitude and behavior regarding fertility issues for young breast cancer patients: a national survey for breast care specialists. Breast Cancer 20:230–240PubMedCrossRef Shimizu C, Bando H, Kato T, Mizota Y, Yamamoto S, Fujiwara Y (2013) Physician’s knowledge, attitude and behavior regarding fertility issues for young breast cancer patients: a national survey for breast care specialists. Breast Cancer 20:230–240PubMedCrossRef
8.
go back to reference Quinn GP, Vadaparampil ST, Lee JH et al (2009) Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol 27:5952–5957PubMedCrossRef Quinn GP, Vadaparampil ST, Lee JH et al (2009) Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol 27:5952–5957PubMedCrossRef
9.
10.
go back to reference Valachis A, Tsali L, Pesce LL et al (2011) Safety of pregnancy after primary breast carcinoma in young women: a meta-analysis to overcome bias of healthy mother effect studies. Obstet Gyn Survey 65:786–793CrossRef Valachis A, Tsali L, Pesce LL et al (2011) Safety of pregnancy after primary breast carcinoma in young women: a meta-analysis to overcome bias of healthy mother effect studies. Obstet Gyn Survey 65:786–793CrossRef
11.
go back to reference Azim HA, Kroman N, Paesmans M et al (2013) Prognostic impact of pregnancy after breast cancer according to estrogen receptor status. J Clin Oncol 31:73–79PubMedCentralPubMedCrossRef Azim HA, Kroman N, Paesmans M et al (2013) Prognostic impact of pregnancy after breast cancer according to estrogen receptor status. J Clin Oncol 31:73–79PubMedCentralPubMedCrossRef
12.
go back to reference Azim AA, Costantini-Ferrando M, Oktay K (2008) Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol 26(16):2630-5 Azim AA, Costantini-Ferrando M, Oktay K (2008) Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol 26(16):2630-5
13.
go back to reference Pagani O, Partridge A, Korde L et al (2011) Pregnancy after breast cancer: if you wish, ma’am. Breast Cancer Res Treat 129:309–317PubMedCrossRef Pagani O, Partridge A, Korde L et al (2011) Pregnancy after breast cancer: if you wish, ma’am. Breast Cancer Res Treat 129:309–317PubMedCrossRef
14.
go back to reference The Ethics Committee of the American Society for Reproduction Medicine (2005) Fertility preservation and reproduction in cancer patients. Fertil Steril 83:1622–1628CrossRef The Ethics Committee of the American Society for Reproduction Medicine (2005) Fertility preservation and reproduction in cancer patients. Fertil Steril 83:1622–1628CrossRef
15.
go back to reference Sha DK, Goldman E, Fisseha S (2011) Medical, ethical and legal consideration in fertility preservation. Int J Gynaecol Obstet 115:11–15CrossRef Sha DK, Goldman E, Fisseha S (2011) Medical, ethical and legal consideration in fertility preservation. Int J Gynaecol Obstet 115:11–15CrossRef
16.
go back to reference Rodriguez S, Campo-Engelstein L, Emanuel L (2013) Fertile future? Potential social implications of oncofertility. J Clin Oncol 31:665–667PubMedCrossRef Rodriguez S, Campo-Engelstein L, Emanuel L (2013) Fertile future? Potential social implications of oncofertility. J Clin Oncol 31:665–667PubMedCrossRef
17.
go back to reference Gracia CR, Jeruss JS (2013) Lives in the balance: women with cancer and the right to fertility care. J Clin Oncol 31:668–669PubMedCrossRef Gracia CR, Jeruss JS (2013) Lives in the balance: women with cancer and the right to fertility care. J Clin Oncol 31:668–669PubMedCrossRef
Metadata
Title
Perception and needs of reproductive specialists with regard to fertility preservation of young breast cancer patients
Authors
Chikako Shimizu
Tomoyasu Kato
Nobuko Tamura
Hiroko Bando
Yoshimasa Asada
Yuri Mizota
Seiichiro Yamamoto
Yasuhiro Fujiwara
Publication date
01-02-2015
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 1/2015
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-014-0676-4

Other articles of this Issue 1/2015

International Journal of Clinical Oncology 1/2015 Go to the issue

Introduction to Review Articles

Cancer registration system: an introduction

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine